These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28627763)

  • 21. Naloxone Access and Use for Suspected Opioid Overdoses.
    Ann Emerg Med; 2017 Jul; 70(1):112-113. PubMed ID: 28645392
    [No Abstract]   [Full Text] [Related]  

  • 22. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quetiapine and other antipsychotics combined with opioids in legal autopsy cases: A random finding or cause of fatal outcome?
    Andersen FD; Simonsen U; Andersen CU
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):66-79. PubMed ID: 33245632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
    Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
    J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of naloxone for overdose prevention to chronic pain patients.
    Coe MA; Walsh SL
    Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overdose education and naloxone distribution for veterans with opioid use disorder: Results from a pilot initiative.
    Chang G; Davids M; Kershaw A
    J Addict Dis; 2017; 36(4):217-221. PubMed ID: 28548574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspiration in lethal drug abuse-a consequence of opioid intoxication.
    Nicolakis J; Gmeiner G; Reiter C; Seltenhammer MH
    Int J Legal Med; 2020 Nov; 134(6):2121-2132. PubMed ID: 32929594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naloxone Conundrum: Reduce risk in managing the opioid overdose patient.
    Wirth SR
    JEMS; 2016 Nov; 41(11):14-5. PubMed ID: 29188938
    [No Abstract]   [Full Text] [Related]  

  • 29. Methadone-related deaths in Montpellier and Region, from 2000 to 2010.
    Eiden C; Cathala P; Mathieu-Daude JC; Marson B; Baccino E; Leglise Y; Peyrière H
    Therapie; 2012; 67(6):515-22. PubMed ID: 23249577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute respiratory distress syndrome caused by methadone syrup.
    Aghabiklooei A; Shadnia S; Hassanian-Moghaddam H; Zamani N
    Arh Hig Rada Toksikol; 2013 Sep; 64(3):439-43. PubMed ID: 24084353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts.
    Sumner SA; Mercado-Crespo MC; Spelke MB; Paulozzi L; Sugerman DE; Hillis SD; Stanley C
    Prehosp Emerg Care; 2016; 20(2):220-5. PubMed ID: 26383533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of Opioid-Induced Ventilatory Depression Using Low-Dose Naloxone (0.04 mg): a Case Series.
    Kim HK; Nelson LS
    J Med Toxicol; 2016 Mar; 12(1):107-10. PubMed ID: 26289651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methadone related deaths compared to all prescription related deaths.
    Lev R; Petro S; Lee A; Lee O; Lucas J; Castillo EM; Egnatios J; Vilke GM
    Forensic Sci Int; 2015 Dec; 257():347-352. PubMed ID: 26513639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxycodone overdose causes naloxone responsive coma and QT prolongation.
    Berling I; Whyte IM; Isbister GK
    QJM; 2013 Jan; 106(1):35-41. PubMed ID: 23023890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment.
    Mégarbane B; Buisine A; Jacobs F; Résière D; Chevillard L; Vicaut E; Baud FJ
    J Subst Abuse Treat; 2010 Jun; 38(4):403-7. PubMed ID: 20189341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
    Srivastava A; Kahan M; Nader M
    Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxone (Narcan) nasal spray for opioid overdose.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):1-2. PubMed ID: 26714239
    [No Abstract]   [Full Text] [Related]  

  • 38. Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders.
    Green TC; Bowman SE; Zaller ND; Ray M; Case P; Heimer R
    Subst Use Misuse; 2013 May; 48(7):558-67. PubMed ID: 23647168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.
    Rudd RA; Aleshire N; Zibbell JE; Gladden RM
    MMWR Morb Mortal Wkly Rep; 2016 Jan; 64(50-51):1378-82. PubMed ID: 26720857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Walley AY; Doe-Simkins M; Quinn E; Pierce C; Xuan Z; Ozonoff A
    J Subst Abuse Treat; 2013 Feb; 44(2):241-7. PubMed ID: 22980450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.